article_snippet.sent: The vaccine, developed in Canada, is based on an animal virus called vesicular stomatitis virus (VSV) that is combined with a portion of the protein covering of Ebola virusEbola virus.
article_snippet.sent: When administered, it induces an immune response against Ebola virus.
article_snippet.sent: Dr Michael Ramharter, of the Medical Research Unit at Albert Schweitzer Hospital, Lambarene, Gabon, said an immune response against the Ebola virus is inserted into the vaccine as a Trojan horse to get the body to develop an immune response against Ebola virus.
article_snippet.sent: Dr Michael Ramharter, of the Medical Research Unit at Albert Schweitzer Hospital, Lambarene, Gabon said: 'An Ebola glycoprotein from the Ebola strain in Zaire is being inserted into the vaccine.
article_snippet.sent: While VSV only causes mild symptoms in humans, an immune response against the Ebola virus acts as an Ebola antigen and triggers the formation of antibodies against the disease in the immune system.'
article_snippet.sent: Dr Ramharter said an immune response against the Ebola virus hide, almost like a 'Trojan horse', in the body in order to successfully fight Ebola virus if the individual becomes infected.
article_snippet.sent: Dr Ramharter added: 'Just one vaccine has conferred one hundred per cent protection against Ebola in the initial trials on primates.'
article_snippet.sent: The race is on to find ways to prevent and cure the Ebola virus as there are no proven treatments or vaccines to prevent individuals becoming infected.
highlights_snippet.sent: Vaccine based on animal virus and the protein covering of Ebola virus .
  
highlights_snippet.sent: Ebola antigen in vaccine acts as 'Trojan horse' to create immune response .
  